Effects of trapidil on intestinal mucosal barrier function and bacterial translocation after intestinal ischemia and reperfusion in an experimental rat model

Current Therapeutic Research - Clinical and Experimental

Volumn 64, Issue 6, 2003, Pages 355-366

  Colak, Tahsin ^a   Ozturk, Candan ^a   Polat, Ayse ^a   Bagdatoglu, Ozlen ^a   Kanik, Arzu ^a   Turkmenoglu, Ozgur ^a   Aydin, Suha ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Bacterial translocation; Ischemia reperfusion; Mucosal barrier dysfunction; Trapidil

Indexed keywords

CYTOKINE; LIPID PEROXIDE; MALONALDEHYDE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; SODIUM CHLORIDE; THROMBOXANE A2; TRAPIDIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; INTESTINE ISCHEMIA; INTESTINE MUCOSA; LIPID PEROXIDATION; LIVER; MALE; MESENTERY LYMPH NODE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SPLEEN;

EID: 0042201913     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(03)00091-2     Document Type: Article

References (25)

1. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science. 1996;272:50-53.
2. Wells CL, Maddaus MA, Simmons RL. Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis. 1988;10:958-979.
3. Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol. 1986;250:749-753.
4. Block HU, Dunemann A, Niebisch M, Mest HJ. Influence of the antianginal drug trapidil and its derivative AR 12463 on arachidonic acid liberation and thromboxane formation in thrombin-stimulated platelets. Biomed Biochim Acta. 1988;47(Suppl): S141-S144.
5. 2 production by trapidil and trapidil derivatives in the arachidonic acid-injected rat. Prostaglandins Leukot Med. 1987;30:87-92.
6. Zhou L, Ismaili J, Stordeur P, et al. Inhibition of the CD40 pathway of monocyte activation by triazolopyrimidine. Clin Immunol. 1999;93:232-238.
7. Bagdatoglu C, Saray A, Surucu HS, et al. Effect of trapidil in ischemia/reperfusion injury of peripheral nerves. Neurosurgery. 2002;51:212-219.
8. Colak T, Polat A, Bagdatoglu O, et al. Effect of trapidil in ischemia/reperfusion injury on rat small intestine. J Invest Surg. 2003;16:1-10.
9. Sun Z, Wang X, Lasson A, et al. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. Scand J Gastroenterol. 2001;36:55-65.
10. Yagi K. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol. 1998;108:107-110.
11. Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970;101: 478-483.
12. Isenberg HD. Clinical Microbiology Procedures Handbook. Washington, DC: American Society of Microbiology; 1992:1.15.5-1.17.6.
13. Floyd RA. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 1990;4:2587-2597.
14. Hirata Y, Taguchi T, Nakao M, et al. The relationship between the adenine nucleotide metabolism and the conversion of the xanthine oxidase enzyme system in ischemia-reperfusion of the rat small intestine. J Pediatr Surg. 1996;31:1199-1204.
15. Demediuk P, Saunders RD, Anderson DK, et al. Membrane lipid changes in laminectomized and traumatized cat spinal cord. Proc Natl Acad Sci U S A. 1985;82:7071-7075.
16. Gocer AI, Ildan F, Tuna M, et al. Effects of trapidil on ATPase, lipid peroxidation, and correlation with ultrastructure in experimental spinal cord injury. Neurosurg Rev. 2001;24:136-142.
17. Ceran C, Sonmez K, Turkyllmaz Z, et al. Effect of bilirubin in ischemia/reperfusion injury on rat small intestine. J Pediatr Surg. 2001;36:1764-1767.
18. Sener G, Akgun U, Satiroglu H, et al. The effect of pentoxifylline on intestinal ischemia/reperfusion injury. Fundam Clin Pharmacol. 2001;15:19-22.
19. Blank I, Baudisch W, Burmeister J, Franz U. Effect of amrinone and trapidil on adherence, migration and phagocytic behavior of neutrophilic granulocytes of the human [in German]. Folia Haematol Int Mag Klin Morphol Blutforsch. 1987;114: 760-767.
20. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992;216:117-134.
21. Kawamura T, Kitani T, Okajima Y, et al. Effect of trapidil on prostacyclin generation of arterial wall. Prostaglandins Med. 1980;5:113-121.
22. Simpson R, Alon R, Kobzik L, et al. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg. 1993;218:444-453.
23. Franciose RJ, Moore EE, Moore FA, et al. Hypoxia/reoxygenation of human endothelium activates PMNs to detach endothelial cells via a PAF mechanism. J Surg Res. 1996;61:459-462.
24. Paterson IS, Klausner JM, Goldman G, et al. Thromboxane mediates the ischemia-induced neutrophil oxidative burst. Surgery. 1989;106:224-229.
25. Goldman G, Welbourn R, Klausner JM, et al. Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1. Circ Res. 1991;68:1013-1019.